ALTERNATING WEEKLY TEMOZOLOMIDE AS INITIAL TREATMENT FOR PROGRESSIVE LOW-GRADE OLIGODENDROGLIAL TUMORS: A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY

被引：0
|
作者：
Soffietti, Riccardo [1 ]
Roda, Roberta [1 ]
Trevisan, Elisa [1 ]
Laguzzi, Elena [1 ]
Picco, Elisabetta [1 ]
Guarneri, Dainele [1 ]
Caroli, Manuela [2 ]
Crippa, Flavio [3 ]
机构：
[1] Univ Turin, Turin, Italy
[2] Univ Milan, Milan, Italy
[3] Ist Nazl Tumori, I-20133 Milan, Italy
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：838 / 838
页数：1
相关论文
共 50 条
  • [21] IDH-WILD TYPE GRADE II GLIOMAS: A RETROSPECTIVE SERIES OF AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY)
    Bruno, F.
    Silvani, A.
    Ius, T.
    Bello, L.
    Minniti, G.
    Pace, A.
    Lombardi, G.
    Soffietti, R.
    Ruda, R.
    NEURO-ONCOLOGY, 2018, 20 : 220 - 221
  • [22] Bevacizumab and Fotemustine for Recurrent Glioblastoma - Final Results of a Multicenter Phase II Study of AINO (Italian Association of Neuro-Oncology)
    Trevisan, E.
    Ruda, R.
    Bertero, L.
    Bosa, C.
    Ciccone, G.
    Morra, I.
    Fabrini, M. G.
    Lolli, I.
    Soffietti, R.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S576 - S576
  • [23] Correction to: Efficacy of initial temozolomide for high‑risk low grade gliomas in a phase II AINO (Italian Association for Neuro‑Oncology) study: a post‑hoc analysis within molecular subgroups of WHO 2016
    Roberta Rudà
    Alessia Pellerino
    Andrea Pace
    Carmine Maria Carapella
    Cristina Dealis
    Manuela Caroli
    Marina Faedi
    Lorenzo Bello
    Enrica Migliore
    Giulia Marchese
    Luca Bertero
    Paola Cassoni
    Riccardo Soffietti
    Journal of Neuro-Oncology, 2019, 145 : 593 - 593
  • [24] PHASE II TRIAL OF BEVACIZUMAB WITH FOTEMUSTINE IN RECURRENT GLIOBLASTOMA: FINAL RESULTS OF A MULTICENTER STUDY OF AINO (ITALIAN ASSOCIATION OF NEURO-ONCOLOGY)
    Soffietti, Riccardo
    Trevisan, Elisa
    Ruda, Roberta
    Bertero, Luca
    Bosa, Chiara
    Fabrini, Maria Grazia
    Lolli, Ivan
    NEURO-ONCOLOGY, 2011, 13 : 56 - 57
  • [25] Phase II trial of bevacizumab with fotemustine in recurrent glioblastoma: Final results of a multicenter study of AINO (Italian Association of Neuro-oncology).
    Soffietti, R.
    Trevisan, E.
    Ruda, R.
    Bertero, L.
    Bosa, C.
    Fabrini, M. G.
    Lolli, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016 (vol 145, pg 115, 2019)
    Ruda, Roberta
    Pellerino, Alessia
    Pace, Andrea
    Carapella, Carmine Maria
    Dealis, Cristina
    Caroli, Manuela
    Faedi, Marina
    Bello, Lorenzo
    Migliore, Enrica
    Marchese, Giulia
    Bertero, Luca
    Cassoni, Paola
    Soffietti, Riccardo
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (03) : 593 - 593
  • [27] Temozolomide (TMZ) and radiation therapy (RT) combination in elderly patients with glioblastoma: A multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
    Lombardi, Giuseppe
    Pace, Andrea
    Pasqualetti, Francesco
    Rizzato, Simona
    Faedi, Marina
    Anghileri, Elena
    Nicolotto, Elisa
    Bazzoli, Elena
    Bellu, Luisa
    Villani, Veronica
    Fabi, Alessandra
    Ferrazza, Patrizia
    Gurrieri, Lorena
    Dall'Agata, Monia
    Eoli, Marica
    Della Puppa, Alessandro
    Pambuku, Ardi
    D'Avella, Domenico
    Ruda, Roberta
    Zagonel, Vittorina
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Clinical and molecular predictors of survival in elderly glioblastoma patients treated with radiotherapy and concomitant temozolomide: a multicenter study of aino (Italian Association of Neuro-Oncology)
    Lombardi, G.
    Pace, A.
    Pasqualetti, F.
    Rizzato, S.
    Faedi, M.
    Anghileri, E.
    Nicolotto, E.
    Bazzoli, E.
    Bellu, L.
    Villani, V.
    Fabi, A.
    Ferrazza, P.
    Gurrieri, L.
    Dall'Agata, M.
    Eoli, M.
    Della Puppa, A.
    Pambuku, A.
    Berti, F.
    Ruda, R.
    Zagonel, V.
    ANNALS OF ONCOLOGY, 2015, 26 : 136 - 136
  • [29] Cyclophosphamide for the treatment of progressive low-grade astrocytoma: A pediatric oncology group phase II study
    Kadota, RP
    Kun, LE
    Langston, JW
    Burger, PC
    Cohen, ME
    Mahoney, DH
    Walter, AW
    Rodman, JH
    Parent, A
    Buckley, E
    Kepner, JL
    Friedman, HS
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (03) : 198 - 202
  • [30] A PHASE II STUDY OF AINO (ITALIAN ASSOCIATIONOF NEURO-ONCOLOGY) ON BEVACIZUMAB AND FOTEMUSTINE FOR RECURRENT GLIOBLASTOMA: OUTCOME, PATTERNS OF RELAPSE AND SALVAGE TREATMENTS
    Trevisan, E.
    Bertero, L.
    Cassoni, P.
    Morra, I.
    Pasqualetti, F.
    Lolli, I.
    Castiglione, A.
    Ciccone, G.
    Ruda, R.
    Soffietti, R.
    NEURO-ONCOLOGY, 2014, 16
12345